Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-α

British Journal of Cancer

Volumn 80, Issue 5-6, 1999, Pages 705-710

  Hung, W C ^a   Chuang, L Y ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cyclin D1; Hepatoma; Interferon; p21(WAF 1); Retinoblastoma protein; Sodium butyrate

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BUTYRIC ACID; CYCLIN D1; DNA FRAGMENT; PROTEIN P21; RECOMBINANT ALPHA INTERFERON; RETINOBLASTOMA PROTEIN; STAT1 PROTEIN; TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; NUCLEOSOME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BUTYRIC ACID; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL DIVISION; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; G1 PHASE; HUMANS; INTERFERON TYPE I, RECOMBINANT; LIVER NEOPLASMS; NEOPLASM PROTEINS; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032895097     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690413     Document Type: Article

References (34)

1. Alexander GJ, Brahm J, Fagan EA, Smith HM, Daniels HM, Eddleston AL and Williams R (1987) Loss of HBsAg with interferon therapy in chronic hepatitis virus infection. Lancet 2: 66-69
2. Boue F, Pastran Z, Spielmann M, Chevalier TL, Subirana R, Sevin D, Paoletti C, Brandely M, Avril MF, Sancho-Garnier H and Tursz T (1990) A phase I trial with recombinant interferon γ (Rousell UCLAF) in advanced cancer patients. Cancer Immunol Immunother 32: 67-70
3. WAF1/CIP1 mediated by STAT1. Science 272: 719-722
4. Chin YE, Kitagawa M, Kuida K, Flavell RA and Fu XY (1997) Activation of the STAT signaling pathway can cause expression of caspase I and apoptosis. Mol Cell Biol 17: 5328-5337
5. Darnell JE Jr (1997) STATs and gene regulation. Science 277: 1630-1635
6. Decker T, Lew DJ and Darnell JE Jr (1991) Two distinct alpha-interferon dependent signal transduction pathways may contribute to activation of transcription to the guanylate-binding protein gene. Mol Cell Biol 13: 5147-5153
7. El-Deiry W, Tokmo T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B (1993) WAF-1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
8. El-Deiry W, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174
9. Foster GR, Ackrill AM, Goldin RD, Kerr IM, Thomas HC and Stark GR (1991) Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferon α and γ double-stranded RNA. Proc Natl Acad Sci USA 88: 2888-2892
10. Goto I, Yamamoto-Yamagichi Y and Honma Y (1996) Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon α by differentiation-inducing agents. Br J Cancer 74: 546-554
11. Gutterman JU (1994) Cytokine therapeutics: lessons from interferon α. Proc Natl Acad Sci USA 91: 1198-1205
12. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ (1993) The P21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin dependent kinases. Cell 75: 805-816
13. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP and Wei N (1995) Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6: 387-400
14. Hung WC and Chuang LY (1996) Induction of apoptosis by sphingosine-1 phosphate in human hepatoma cells is associated with enhanced expression of bax gene product. Biochem Biophys Res Commun 229: 11-15
15. Hung WC, Yang ML, Chang CC, Tsai JH and Chuang LY (1995) Differential regulation of EGF production, EGF receptor binding, and cellular growth by sodium butyrate in Hep3B and PLC/PRF/5 human hepatoma cells. Inter J Oncol 7: 1089-1093
16. Kolla V, Lindner DJ, Weihua X, Borden EC and Kalvakolanu DV (1996) Modulation of interferon-inducible gene expression by retinoic acid: up regulation of STAT1 protein in interferon-unresponsive cells. J Biol Chem 271: 10508-10514
17. Korenman J, Baker B, Waggoner J, Everhart JE, Di-Bisceglie AM and Hoofnagle JH (1991) Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 114: 629-634
18. Kumar S (1995) ICE-like proteases in apoptosis. Trends Biochem Sci 20: 198-202
19. Lai CL, Wu PC, Lok ASF, Lin HJ, Ngan H, Lau JYN, Chung HT, Ng MMT, Yeoh EK and Amold M (1989) Recombinant interferon α2 is superior to doxorubin for inoperable hepatocellular carcinoma: a prospective randomised trial. Br J Cancer 60: 928-933
20. Lee CK, Bluyssen HAR and Levy DE (1997) Regulation of interferon-α responsiveness by the duration of janus kinase activity. J Biol Chem 272: 21872-21877
21. Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JC and Hong WK (1992a) 13-cis-retinoic acid and interferon α-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84: 235-241
22. Lippman SM, Kavanagh JJ, Pareds-Espinoza M, Delgadillo-Madrueno P, Paredes-Casillas P, Hong WK, Holdener E and Krakoff IH (1992b) 13-cis-retinoic acid plus interferon α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84: 241-245
23. Muller M, Laxton C, Brisene J, Schindler C, Improta T, Darnell JE Jr, Stark GR and Kerr IM (1993) Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J 12: 4221-4228
24. Nair PV, Tong MJ, Kempf R, Co R, Lee SD and Venturi CL (1985) Clinical serologic and immunological effects of human leukocyte interferon in HBsAg-positive primary hepatocellular carcinoma. Cancer 56: 1018-1023
25. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyam Y, Fujita T, Ohtani-Fujita N, Matsukawa Y, Tokino T, Yamagishi H, Oka T, Nomura H and Sakai T (1997) Butyrate activates the WAF1/CIP1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem 272: 22199-22206
26. Pelicano L, Li F, Schindler C and Chelbi Alix MK (1997) Retinoic acid enhances the expression of interferon-induced proteins: evidence for multiple mechanisms of action. Oncogene 15: 2349-2359
27. Pellegrini S and Dusanter Fourt I (1997) The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur J Biochem 248: 615-633
28. Sachs E, Di-Biscegle AM, Dusheiko GM, Song E, Lyons SF, Schoub BD and Kew MC: (1985) Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study. Br J Cancer 52: 105-109
29. Tuf-Kaspa R, Teicher L, Laub O, Itin A, Dagan D Bloom BR and Shalritz DA (1990) Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription. Virol 64: 1821-1824
30. Weihua X, Kolla V and Kalvakolanu DV (1997) Modulation of interferon action by retinoids: induction of murine STAT1 gene expression by retinoic acid. J Biol Chem 272: 9742-9748
31. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704
32. Xu B, Grander D, Sangfelt O and Einhorn S (1994) Primary leukemia cells resistant to α-interferon in vitro are defective in the activation of the DNA-binding factor interferon stimulated gene factor 3. Blood 84: 1942-1949
33. Yamamoto K, Quelle FW, Thierfelder WE, Kreider BL, Gilbert DJ, Jenkins NA, Copeland NG, Silvennoinen O and Ihle JN (1994) Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol 14: 4342-4349
34. Zhang P and McLachlan A (1994) Differentiation-specific transcriptional regulation of the hepatitis B virus nucleocapsid gene in human hepatoma cell lines. Virology 202: 430-440